Evidence map›Paper›PMID 38024306›Full record

ArticleNanoscale advances2023

Sam Morris, Mark Long, Alison Savage, Andrew Owen, Steve Rannard, Helen Cauldbeck

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sam MorrisRadiomaterials Laboratory, Department of Chemistry, University of Liverpool Crown Street Liverpool L69 7ZD UK helen.cauldbeck@liverpool.ac.uk.ORCID https://orcid.org/0000-0001-9746-5266
Mark LongUnilever Research Centre Port Sunlight, Quarry Road East, Bebington Wirral CH63 3JW UK.
Alison SavageCentre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool Liverpool L7 3NY UK.ORCID https://orcid.org/0000-0002-5312-9946
Andrew OwenCentre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool Liverpool L7 3NY UK.ORCID https://orcid.org/0000-0002-9819-7651
Steve RannardCentre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool Liverpool L7 3NY UK.ORCID https://orcid.org/0000-0002-6946-1097
Helen CauldbeckRadiomaterials Laboratory, Department of Chemistry, University of Liverpool Crown Street Liverpool L69 7ZD UK helen.cauldbeck@liverpool.ac.uk.ORCID https://orcid.org/0000-0002-2853-8457

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inherent barrier properties of the skin impose significant challenges to the transdermal delivery of drugs to systemic circulation. Here, the

Identifiers

PMID38024306
PMCPMC10662085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.